Maja Reimann
Luebeck, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
PD-L1-centric whole blood-based immune signature profiles of tuberculosis patients during therapy.
Journal: Frontiers in immunology
Published: March 12, 2026
Diagnostic Yield of Nontuberculous Mycobacteria Testing in Patients with Chronic Lung Diseases: A Retrospective Cohort Study.
Journal: Infection and drug resistance
Published: February 17, 2026
Lipoarabinomannan (LAM) for the diagnosis of tuberculosis from sputum.
Journal: The Journal of infection
Published: November 09, 2025
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation study.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: October 06, 2025
High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 14, 2025
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
Journal: Emerging infectious diseases
Published: March 02, 2025
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: December 09, 2024
The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion.
Journal: Pathogens & immunity
Published: October 29, 2024
Blood levels of Mycobacterium tuberculosis (Mtb)antigen-triggered immune markers in people exposed to tuberculosis with regard to Mtb infection status and receipt of tuberculosis preventive therapy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: October 25, 2024
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe.
Journal: IJTLD open
Published: September 23, 2024
Last Updated: 09/26/2026